News & Updates

The presence of atrial fibrillation (AF) at baseline does not appear to modify the benefits of dapagliflozin, compared with placebo, on symptoms and clinical events in patients with heart failure and preserved ejection fraction (HFpEF) or mildly reduced ejection fraction (HFmrEF), according to a study.

Patients with severe obesity and nonalcoholic fatty liver disease (NAFLD) appear to benefit from bariatric surgery, which significantly reduces the risk of cardiovascular disease (CVD), a study has found.

Aortic stiffness, pressure wave reflections (PWRs), and their combined incremental value play pivotal roles in predicting long-term survival, morbidity, and functional disability in patients with acute stroke, suggest the results of a study.

Patients with biopsy-proven alcohol-related liver disease (ALD) appear to have a higher frequency of cardiovascular disease (CVD) than their counterparts without ALD, according to a study. The increased rates are especially pronounced just after ALD diagnosis.

Kidney transplant recipients from living donors with hypertension are at significantly increased risk of renal allograft loss compared to those from normotensive living donors, reveals a study. Moreover, outcomes are similar to recipients of normotensive deceased donors.

Patients who are on long-term statin therapy may have a reduced risk of severe COVID-19–related outcomes including mortality, intensive care unit (ICU) admission, and requirement for mechanical ventilation, according to a study presented at Anesthesiology 2022.